Efficacy of Early Combination Therapy With Lianhuaqingwen and Arbidol in Moderate and Severe COVID-19 Patients: A Retrospective Cohort Study

OBJECTIVE: Since the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Wuhan City, China, coronavirus disease 2019 (COVID-19) has become a global pandemic. However, no special therapeutic drugs have been identified for COVID-19. The aim of this study was to search for drugs...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Fang, Jie, Li, Hui, Du, Wei, Yu, Ping, Guan, Ying-Yun, Ma, Shi-Yu, Liu, Dong, Chen, Wei, Shi, Guo-Chao, Bian, Xiao-Lan
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7530276/
https://ncbi.nlm.nih.gov/pubmed/33071781
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.560209
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados